All News

REMS for opioids may present some tough challenges for pharmacists.

Whether mail-order pharmacy is a blessing or a bane depends on whom you ask.

A survey of new Rx and new OTC

How to understand the difference between term and permanent life insurance.

More than $600,000 of unused medications were donated to Kansas clinics last year.

Walgreens' planned acquisition of Duane Reade signals further advances into pharmacy and drugstore retailing for the smaller chain.

While the government deems that marijuana has a "high potential for abuse" and "has no currently accepted medical use," some states have undertaken initiatives to pass legislation permitting its use for pain control and for control of nausea and vomiting by cancer patients.

The Institute of Medicine says more research is necessary comparing the advantages of different sites for vaccination.

Technology now exists that can verify the contents of a drug vial or syringe, benefiting retailers, hospitals, and manufacturers.

Medication therapy management programs are intended to improve patient outcomes and reduce healthcare costs. Community pharmacist Tony Bastian offers a detailed report on how MTM is working at his pharmacy.

George Barrett of Cardinal Health discusses the future of independent pharmacists.

Pharmacy and Therapeutics committees around the country are taking a second look at what they're using for pediatric rehydration and how much they're willing to pay.

Norditropin FlexPro (somatropin [rDNA origin] injection, Novo Nordisk), a pre-filled injection pen for use in children and adults with growth hormone disorders, will be available this spring.

An FDA-approved oral transmucosal fentanyl citrate, an opioid analgesic for cancer pain management, is being launched by Mallinckrodt Inc., a Covidien company.

Cabazitaxel, an investigational compound under development by Sanofi-aventis, plus prednisone/prednisolone, is associated with overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease advanced after treatment with docetaxel-based chemotherapy.

Data from the Phase III trial of Zelrix, a transdermal patch under development by NuPathe Inc. for management of acute migraine, showed the patch met the primary efficacy endpoint.

The FDA-approved Iprivask (desirudin for injection, Canyon Pharmaceuticals), now available, marks the first direct thrombin inhibitor (DTI) OK'd for the prevention of deep vein thrombosis (DVT).

Despite a challenging 2009-10 winter, the majority of pharmacists across 26 states (79 percent of respondents) that were affected by the snow largely managed to keep standard business hours, according to a new survey.

Pharmacists speak out about Medicaid patients, professional organizations, medication therapy management, and more.

Since February is National Children's Dental Health Month, it's an appropriate time to introduce new oral care products for children and adults.

Cutbacks to Washington's Medicaid reimbursements have resulted in Walgreens receiving below its cost or break-even point on nearly 95 percent of brand-name medications.

Patient counseling and medication management therapy: You do the math.

Most agents used for presurgical prophylaxis are not effective against MRSA. To reduce MRSA-related surgical site infections,says one expert, you need to prevent all SSIs.

The following months promise the appearance on the market of a diverse group of new drug therapies. Breakthroughs will include drugs for the treatment of Alzheimer's disease and cardiovascular disease.

Financial adviser Rick Schultenover discusses how to distinguish between a Roth IRA and 401k.

Compounding is still the quintessential art of a pharmacist.

Operational efficiences and economies of scale resulting from its 2008 merger with RxHub have enabled Surescripts to cut its pharmacy routing and transaction fees, which should lead to decreases in the prices independent pharmacies are paying.

As you look back over your life and career, what makes you most proud?

Pharmacies are experiencing financial, regulatory and reimbursement challenges that have increased pressure on their operations. A regular review of financial circumstances and business options can help pharmacies stay afloat in turbulent times.

As their growing role in healthcare causes pharmacists to focus more on medication management and patient consulting, some are specializing in healthcare issues and needs specific to women.